Investor Home

Corporate Profile

Apricus is committed to developing sexual health therapies in areas of high unmet needs. We have disciplined leadership focused on execution and are driving near-term shareholder value through regulatory approval, commercialization and partnering initiatives.

Recent Newsmore >
DateTitle
08/15/16Apricus Biosciences Announces Completion of Transfer of the United Kingdom Marketing Authorization for Vitaros® to Ferring Pharmaceuticals
SAN DIEGO, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Ferring Pharmaceuticals, the Company’s new partner in the United Kingdom, has received the United Kingdom marketing authorization for Vitaros®. “We are pleased that the transfer of the U.K. marketing authorization to Ferring has been completed and we look forward to the product’s continued growth in... 
08/10/16Apricus Biosciences Announces Completion of Transfer of Vitaros® German Marketing Authorization to Ferring Pharmaceuticals
SAN DIEGO, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Ferring Pharmaceuticals, the Company’s new partner in Germany, has received the German marketing authorization for Vitaros®. “We are pleased that the transfer of the German marketing authorization to Ferring, a critical step in Ferring’s plan to re-launch Vitaros in this important market, has been c... 
08/04/16Apricus Biosciences Provides Corporate Update and Second Quarter Financial Results
Strategic Focus on Growing Global Vitaros® Revenue and Achieving Profitability in 2017 Apricus Granted Type B Meeting with FDA to Discuss the Vitaros® U.S. NDA Re-Submission Conference Call / Webcast Today, Thursday, August 4, 2016 at 4:30 p.m. ET SAN DIEGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial results for the second quarter of 2016 and provi... 
Event Calendarmore >
August 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-1123456
78910111213
14151617181920
21222324252627
28293031515253
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.